Navigation Links
Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of company's third US patent for its oxidation-reduction potential diagnostic platform
Date:10/1/2013

important measure in the detection of both critical and chronic illnesses and is a novel marker of patient morbidity across a wide range of diseases and conditions. There are numerous clinical indications for this homeostatic parameter for which there is no currently available test. Luoxis is a majority-owned subsidiary of Ampio Pharmaceuticals, Inc.

About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc. is a development stage biopharmaceutical company focused on the rapid development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. We are developing compounds that decrease inflammation by (i) inhibition of specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level (ii) activation of a specific phosphatase or depletion of the available phosphate needed for the inflammation process and (iii) decreasing vascular permeability – an upstream event in the inflammation cascade.

About the RedoxSYS Diagnostic System
The RedoxSYS diagnostic system is a patented point-of-care diagnostic instrument with accompanying disposable sensors that rapidly measures and reports unique oxidative stress parameters by analyzing a single drop of a blood or plasma. Prior to the development of the RedoxSYS diagnostic system, oxidative stress measurement was incomplete, time consuming and impractical in a clinical setting. The RedoxSYS diagnostic system has clinical application across numerous critical and chronic illnesses. Multiple clinical trials have been completed using the patented RedoxSYS diagnostic system that have demonstrated the predictive value of the oxidative stress biomarkers uniquely measured by the RedoxSYS system.

Forward Looking Statement
Ampio's statements in this press release that are not historical fact and that relate to future plans or events are forward-looking statements within the meaning of the Private Secur
'/>"/>

SOURCE Luoxis Diagnostics; Ampio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Ampio Pharmaceuticals, Inc. Announces Additional Positive Results for Ampion(TM) in Osteoarthritis of the Knee Clinical Trial
2. Ampio Pharmaceuticals, Inc. Announces $25 Million Financing
3. Astellas to Host Executive Womens Day at 2013 TOUR Championship by Coca-Cola
4. Ampio Pharmaceuticals, Inc. Announces Positive Results for Ampion in Osteoarthritis of the Knee Clinical Trial
5. Levine Leichtman Acquires Champion Manufacturing
6. Pro Athletes Team Up to Champion Gout Awareness
7. Dr. Helen Fisher to Speak at Astellas Presents Executive Womens Day at the Constellation SENIOR PLAYERS Championship
8. Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
9. Ampio Pharmaceuticals to List on the NYSE MKT
10. Ampio Pharmaceuticals Provides Clinical Updates
11. Synergy Health Wins Practice Green Health Champion for Change Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 23, 2014  The American Diabetes Association ... target for people with diabetes and that all ... doses of statins, in keeping with recent changes ... the American College of Cardiology (ACC) and American ... the most recent changes to the Association,s annual ...
(Date:12/22/2014)... 22, 2014  CytoSorbents Corporation (OTCQB:CTSOD), a critical ... purification technology to help fight deadly inflammation in ... worldwide, today announced the appointment of Dr. ... its Senior Vice President of Clinical Development, effective ... Di Russo is an accomplished pediatric cardiothoracic ...
(Date:12/22/2014)... 2014 Research and Markets ( ... "Investment Analysis of the US Medical Device ... http://photos.prnewswire.com/prnh/20130307/600769 ... device sector identifies the key trends and rationale ... and mergers and acquisitions. The study ...
Breaking Medicine Technology:New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5Investment Analysis of the US Medical Device Sector 2
... BIRMINGHAM, Ala., Jan. 23 BioCryst,Pharmaceuticals, Inc. ... update on activities,conducted following release of the ... clinical development plan for intramuscular (i.m.) peramivir., ... Following release of preliminary Phase II results ...
... This Month ... at the University of Kentucky, LEXINGTON, Ky., ... on Aging are launching an Alzheimer,s,screening clinical trial with Neuronetrix,s ... assessments,using a technology called event-related potentials (ERP,s). The study is,expected ...
Cached Medicine Technology:BioCryst Updates Peramivir Clinical Development Plan 2BioCryst Updates Peramivir Clinical Development Plan 3BioCryst Updates Peramivir Clinical Development Plan 4BioCryst Updates Peramivir Clinical Development Plan 5BioCryst Updates Peramivir Clinical Development Plan 6Innovative Brain Scanning for Alzheimer's Screening Unveiled 2
(Date:12/25/2014)... 25, 2014 When head lice hits a ... a frenzy to get rid of it while keeping it ... Coral Gables now have the solution right in their neighborhood: ... location, Lice Troopers provides full spectrum head lice screening and ... area, including Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest ...
(Date:12/25/2014)... The risk of burns from fires and cooking accidents ... extra cautious, an expert says. "Between Thanksgiving and ... patients coming in with burns," said Dr. Steven Sandoval, ... Center of Stony Brook University Hospital in New York. ... if not careful, could quickly turn tragic," Sandoval said ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... could be closing in on a "fountain of youth" drug ... health of older adults, a new study suggests. Seniors ... a drug that targets a genetic signaling pathway linked to ... report. The experimental medication, a version of ...
(Date:12/25/2014)... 25, 2014 “ SmileStix ” was featured ... the latest and coolest mobile applications on the iOS, Android, ... host of NewsWatch, conducted the app review and shared with ... personal stickers. , The old saying goes, “A picture says ... words that can describe a single image, because each picture ...
(Date:12/25/2014)... 25, 2014 Each year trauma accounts ... million hospital admissions across the nation (according to ... CDC’s National Hospital Ambulatory Medical Care Survey ... conducted in 2010. They estimated that there were between ... in a primary diagnosis of broken bone or fracture. ...
Breaking Medicine News(10 mins):Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4
... 9 Genomma Lab Internacional, S.A.B. de C.V. ... leading Mexican over-the-counter ("OTC") pharmaceuticals and personal care products ... initiate the operation of a stock repurchase fund according ... Directors for an amount of up to Ps. 100 ...
... Nash Corporation (Nasdaq: KNSY ) today announced ... second quarter ended December 31, 2008 at 7:30 A.M. ... Kaufmann, President and CEO, will be hosting a teleconference ... at 9:00 A.M. Eastern Time. To participate in ...
... for immunized seniors, study found, , , FRIDAY, Jan. 9 (HealthDay ... every year could cut your risk of dying from flu ... isn,t always a perfect match for the strains circulating in ... Medicine study that included 10 flu seasons, worth of ...
... but they could signal later trouble , , FRIDAY, Jan. ... to worry about whether their disease might slow their ... function are accelerated among those with the blood sugar ... issue of Neuropsychology , scientists from the University ...
... Jan. 9 The New Combituck(TM) procedure brings the ... tummy tuck, or abdominoplasty, has been the only option ... after weight fluctuations or child birth. A new procedure, ... abdominal skin and fat layer, without the weeks off ...
... the Centers for Medicare and Medicaid Services (CMS) released ... national coverage determination (NCD). This proposed legislation would allow ... patients with all types of cancer. The proposed decision ... addition to initial diagnosis. Two important items in the ...
Cached Medicine News:Health News:Kensey Nash Corporation Announces Its Second Quarter 2009 Earnings Release Date and Teleconference 2Health News:You're Never Too Old for a Flu Shot 2Health News:You're Never Too Old for a Flu Shot 3Health News:Diabetes Linked to Cognitive Problems 2Health News:Doctors at Allure Medical Spa Are Getting the Results of a Tummy Tuck Without the Downtime 2Health News:SNM praises CMS decision to expand reimbursement for cancer treatment 2
... IMMULITE 2000 assays are ... the IMMULITE 2000, a ... immunoassay analyzer. IMMULITE 2000 ... centralization, and a rapidly ...
... CARDIAC M Myoglobin assay for use ... The Cardiac reader analyzer is a ... include: always ready to use (stand-by ... batch specific data entered automatically using ...
IRMA kit for detection of the cardiac marker Myoglobin...
... The CALBIOTECH INC. (CBI) Prolactin ELISA kit ... prolactin in human serum or plasma. Human ... polypeptide hormone with a molecular weight of ... based on a solid phase direct sandwich ...
Medicine Products: